Skip to main content
SpringerLink
Log in

Cancer du sein de l’homme

  • Chapter
Tumeurs malignes rares

  • 57 Accesses

Résumé

Le cancer du sein chez l’homme est une tumeur rare: il représente moins de 1 % de tous les cancers du sein (1–5) et moins de 1 % de tous les cancers chez l’homme (1–5). Une des plus grandes études observationnelles sur le cancer du sein chez l’homme, utilisant les données de la base SEER américaine (Surveillance, Epidemiology, and End Results) a analysé près de 1500 cancers du sein chez l’homme en comparaison à plus de 216000 cancers du sein chez la femme. Les résultats font clairement apparaître des différences cliniques et histopronostiques par rapport à l’âge de survenue, la taille tumorale, l’envahissement ganglionnaire et la proportion de tumeurs exprimant des récepteurs aux oestrogènes (RE+) entre les malades hommes et femmes (6). Pourtant, la prise en charge quotidienne des cancers du sein chez l’homme s’appuie essentiellement sur les données scientifiques des études réalisées chez les femmes. Les études cliniques chez les hommes sont rares et regroupent une population hétérogène.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Weiss JR, Moysich KB, Swede H (2005) Epidemiology of male breast cancer. Cancer Epidemiol Biomarkers Prev 14: 20–26

    Article  PubMed  Google Scholar 

  2. Giordano SH (2005) A review of the diagnosis and management of male breast cancer. Oncologist 10: 471–9

    Article  PubMed  Google Scholar 

  3. Fentiman IS, Fourquet A, Hortobagyi GN (2006) Male breast cancer. Lancet 367: 595–604

    Article  PubMed  Google Scholar 

  4. Nahleh Z, Girnius S (2006) Male breast cancer: a gender issue. Nat Clin Pract Oncol 3: 428–37

    Article  PubMed  Google Scholar 

  5. Agrawal A, Ayantunde AA, Rampaul R, Robertson JF (2007) Male breast cancer: a review of clinical management. Breast Cancer Res Treat 103: 11–21

    Article  CAS  PubMed  Google Scholar 

  6. Anderson WF, Althuis MD, Brinton LA, Devesa SS (2004) Is male breast cancer similar or different than female breast cancer? Breast Cancer Res Treat 83: 77–86

    Article  PubMed  Google Scholar 

  7. Meguerditchian AN, Falardeau M, Martin G (2002) Male breast carcinoma. Can J Surg 45: 296–302

    PubMed  Google Scholar 

  8. Brinton LA, Richesson DA, Gierach GL, et al. (2008) Prospective evaluation of risk factors for male breast cancer. J Natl Cancer Inst 100: 1477–81

    Article  PubMed  Google Scholar 

  9. Ahn J, Schatzkin A, Lacey JV Jr, et al. (2007). Adiposity, adult weight change, and postmenopausal breast cancer risk. Arch Intern Med 167: 2091–102

    Article  PubMed  Google Scholar 

  10. Frank TS, Deffenbaugh AM, Reid JE, et al. (2002) Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol 20: 1480–90

    Article  CAS  PubMed  Google Scholar 

  11. Teixeira MR, Pandis N, Dietrich CU, et al. (1998) Chromosome banding analysis of gynecomastias and breast carcinomas in men. Genes Chromosomes Cancer 23: 16–20

    Article  CAS  PubMed  Google Scholar 

  12. Guinee VF, Olsson H, Moller T, et al. (1993) The prognosis of breast cancer in males. A report of 335 cases. Cancer 71: 154–61

    Article  CAS  PubMed  Google Scholar 

  13. Willsher PC, Leach IH, Ellis IO, et al. (1997). A comparison outcome of male breast cancer with female breast cancer. Am J Surg 173: 185–8

    Article  CAS  PubMed  Google Scholar 

  14. Macdonald G, Paltiel C, Olivotto IA, Tyldesley S (2005) A comparative analysis of radiotherapy use and patient outcome in males and females with breast cancer. Ann Oncol 16: 1442–8

    Article  CAS  PubMed  Google Scholar 

  15. Ribeiro GG, Swindell R, Harris M, et al. (1996) A review of the management of the male breast carcinoma based on an analysis of 420 treated cases. The Breast 5: 141–6

    Article  Google Scholar 

  16. Cimmino VM, Degnim AC, Sabel MS, et al. (2004) Efficacy of sentinel lymph node biopsy in male breast cancer. J Surg Oncol 86: 74–7

    Article  PubMed  Google Scholar 

  17. Boughey JC, Bedrosian I, Meric-Bernstam F, et al. (2006) Comparative analysis of sentinel lymph node operation in male and female breast cancer patients. J Am Coll Surg 203: 475–80

    Article  PubMed  Google Scholar 

  18. Goyal A, Horgan K, Kissin M, et al. (2004). Sentinel lymph node biopsy in male breast cancer patients. Eur J Surg Oncol 30: 480–3

    Article  CAS  PubMed  Google Scholar 

  19. Flynn LW, Park J, Patil SM, et al. (2008) Sentinel lymph node biopsy is successful and accurate in male breast carcinoma. J Am Coll Surg 206: 616–21

    PubMed  Google Scholar 

  20. Erlichman C, Murphy KC, Elhakim T (1984) Male breast cancer: a 13-year review of 89 patients. J Clin Oncol 2: 903–9

    CAS  PubMed  Google Scholar 

  21. Cutuli B, Lacroze M, Dilhuydy JM, et al. (1995) Male breast cancer: results of the treatments and prognostic factors in 397 cases. Eur J Cancer 31A: 1960–4

    Article  CAS  PubMed  Google Scholar 

  22. Cutuli B (2007) Strategies in treating male breast cancer. Expert Opin Pharmacother 8: 193–202

    Article  CAS  PubMed  Google Scholar 

  23. Chakravarthy A, Kim CR (2002) Post-mastectomy radiation in male breast cancer. Radiother Oncol 65: 99–103

    Article  PubMed  Google Scholar 

  24. Ribeiro G, Swindell R (1992) Adjuvant tamoxifen for male breast cancer. Br J Cancer 65: 252–4

    Article  CAS  PubMed  Google Scholar 

  25. Goss P, Reid C, Pintilie M (1999) Male breast carcinoma: a review of 229 patients who presented to the Princes Margaret Hospital during 40 years: 1955–1996. Cancer 85: 629–39

    Article  CAS  PubMed  Google Scholar 

  26. Giordano SH, Perkins GH, Broglio K, et al. (2005) Adjuvant systemic therapy for male breast carcinoma. Cancer 104: 2359–64

    Article  PubMed  Google Scholar 

  27. Turner KJ, Morley M, Atanassova N, et al. (2000) Effect of chronic administration of an aromatase inhibitor to adult male rats on pituitary and testicular function and fertility. J Endocrinol 164: 225–38

    Article  CAS  PubMed  Google Scholar 

  28. Giordano SH, Hortobagyi GN (2006) Leuprolide acetate plus aromatase inhibition for male breast cancer. J Clin Oncol 24: e42–3

    Article  PubMed  Google Scholar 

  29. Bagley CS, Wesley MN, Young RC (1987) Adjuvant chemotherapy in males with cancer of the breast. Am J Clin Oncol 10: 55–60

    Article  CAS  PubMed  Google Scholar 

  30. Patel HZ, Buzdar AU, Hortobagyi GN (1989) Role of adjuvant chemotherapy in male breast cancer. Cancer 64: 1583–5

    Article  PubMed  Google Scholar 

  31. Yildirim E, Berberoglu U (1998) Male breast cancer: a 22-year experience. Eur J Surg Oncol 24: 548–52

    Article  CAS  PubMed  Google Scholar 

  32. Kantarjian H, Yap HY, Hortobagyi G, et al. (1983) Hormonal therapy for metastatic male breast cancer. Arch Intern Med 143: 237–40

    Article  CAS  PubMed  Google Scholar 

  33. Lopez M, Di Lauro L, Lazzaro B, Papaldo P (1985) Hormonal treatment of disseminated male breast cancer. Oncology 42: 345–9

    Article  CAS  PubMed  Google Scholar 

  34. Kraybill WG, Kaufman R, Kinne D (1981) Treatment of advanced male breast cancer. Cancer 47: 2185–9

    Article  CAS  PubMed  Google Scholar 

  35. Yap HY, Tashima CK, Blumenschein GR, et al. (1980) Chemotherapy for advanced male breast cancer. JAMA 243: 1739–41

    Article  CAS  PubMed  Google Scholar 

  36. Hayashi H, Kimura M, Yoshimoto N, et al. (2008) A case of HER2-positive male breast cancer with lung metastases showing a good response to trastuzumab and paclitaxel treatment. Breast Cancer (In press)

    Google Scholar 

  37. Carmona-Bayonas A (2007) Potential benefit of maintenance trastuzumab and anastrozole therapy in male advanced breast cancer. Breast 16: 323–5

    Article  CAS  PubMed  Google Scholar 

  38. Dimitro NV, Nagpal S, Chitneni S (2008) Management of male breast cancer. Oncol Rev 2: 44–52

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Département d’oncologie medicale INSERM U590, Centre Léon-Bérard, 28, rue Laënnec, 69008, Lyon

    Sana Intidhar Labidi-Galy & Olivier Trédan

Authors
  1. Sana Intidhar Labidi-Galy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Olivier Trédan
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag France, Paris

About this chapter

Cite this chapter

Labidi-Galy, S.I., Trédan, O. (2010). Cancer du sein de l’homme. In: Tumeurs malignes rares. Springer, Paris. https://doi.org/10.1007/978-2-287-72070-3_68

Download citation

  • DOI: https://doi.org/10.1007/978-2-287-72070-3_68

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-287-72069-7

  • Online ISBN: 978-2-287-72070-3

Publish with us

Policies and ethics

Search

Navigation